| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mesenchymal Stem Cells | 31 | 2021 | 1634 | 4.420 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 15 | 2020 | 498 | 2.970 |
Why?
|
| Biocompatible Materials | 24 | 2024 | 1688 | 2.920 |
Why?
|
| Drug Delivery Systems | 23 | 2021 | 2211 | 2.780 |
Why?
|
| Cell Culture Techniques | 17 | 2020 | 1664 | 2.080 |
Why?
|
| Prodrugs | 4 | 2020 | 259 | 1.530 |
Why?
|
| Tissue Adhesives | 7 | 2019 | 173 | 1.510 |
Why?
|
| Adhesives | 3 | 2017 | 65 | 1.390 |
Why?
|
| Polyglycolic Acid | 9 | 2016 | 405 | 1.190 |
Why?
|
| Tissue Engineering | 18 | 2017 | 1870 | 1.140 |
Why?
|
| Nanoparticles | 11 | 2024 | 1940 | 1.050 |
Why?
|
| Organoids | 4 | 2022 | 729 | 1.030 |
Why?
|
| Stem Cells | 10 | 2022 | 3521 | 1.030 |
Why?
|
| Lactic Acid | 9 | 2016 | 1133 | 0.910 |
Why?
|
| Regenerative Medicine | 7 | 2019 | 307 | 0.900 |
Why?
|
| Paneth Cells | 3 | 2022 | 98 | 0.900 |
Why?
|
| Cell Adhesion | 14 | 2015 | 3090 | 0.870 |
Why?
|
| Polymers | 11 | 2019 | 1615 | 0.860 |
Why?
|
| Respiratory Protective Devices | 1 | 2023 | 47 | 0.850 |
Why?
|
| Maleimides | 2 | 2021 | 113 | 0.840 |
Why?
|
| Needles | 4 | 2019 | 451 | 0.840 |
Why?
|
| Cell Movement | 13 | 2015 | 5201 | 0.810 |
Why?
|
| Pediatric Dentistry | 4 | 2022 | 25 | 0.790 |
Why?
|
| Nanostructures | 7 | 2017 | 547 | 0.740 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2017 | 1245 | 0.730 |
Why?
|
| Surface Properties | 16 | 2014 | 1159 | 0.680 |
Why?
|
| Hydrogels | 8 | 2019 | 723 | 0.670 |
Why?
|
| P-Selectin | 8 | 2013 | 597 | 0.670 |
Why?
|
| Animals | 87 | 2024 | 167777 | 0.650 |
Why?
|
| Intestinal Mucosa | 7 | 2024 | 3023 | 0.650 |
Why?
|
| Biosensing Techniques | 4 | 2014 | 649 | 0.630 |
Why?
|
| Nanomedicine | 7 | 2018 | 288 | 0.620 |
Why?
|
| Injections | 2 | 2019 | 830 | 0.620 |
Why?
|
| Liposomes | 3 | 2024 | 777 | 0.610 |
Why?
|
| Gastropoda | 1 | 2017 | 9 | 0.610 |
Why?
|
| Osteoblasts | 4 | 2014 | 1142 | 0.610 |
Why?
|
| Tooth Avulsion | 2 | 2006 | 8 | 0.560 |
Why?
|
| Cell Transplantation | 2 | 2010 | 472 | 0.560 |
Why?
|
| Benzylisoquinolines | 1 | 2016 | 15 | 0.550 |
Why?
|
| Biotechnology | 1 | 2018 | 281 | 0.550 |
Why?
|
| Chemotaxis | 4 | 2015 | 598 | 0.540 |
Why?
|
| Regeneration | 8 | 2024 | 1505 | 0.540 |
Why?
|
| Inflammation | 10 | 2018 | 10719 | 0.530 |
Why?
|
| Intestines | 4 | 2022 | 1906 | 0.510 |
Why?
|
| Mucus | 1 | 2017 | 342 | 0.510 |
Why?
|
| Materials Testing | 7 | 2019 | 861 | 0.510 |
Why?
|
| Microfluidics | 6 | 2016 | 652 | 0.510 |
Why?
|
| Pyloric Antrum | 1 | 2015 | 66 | 0.510 |
Why?
|
| Nanofibers | 2 | 2019 | 66 | 0.490 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2021 | 824 | 0.490 |
Why?
|
| Aptamers, Nucleotide | 3 | 2011 | 163 | 0.490 |
Why?
|
| Cell Communication | 4 | 2016 | 1651 | 0.490 |
Why?
|
| Immunosuppressive Agents | 4 | 2019 | 4158 | 0.480 |
Why?
|
| Indoles | 2 | 2021 | 1828 | 0.480 |
Why?
|
| Biomimetics | 2 | 2015 | 173 | 0.470 |
Why?
|
| Oligosaccharides | 3 | 2011 | 403 | 0.460 |
Why?
|
| Transplantation, Heterologous | 2 | 2021 | 2378 | 0.460 |
Why?
|
| Dentists | 1 | 2016 | 177 | 0.460 |
Why?
|
| Insulin-Secreting Cells | 1 | 2021 | 896 | 0.460 |
Why?
|
| Electric Power Supplies | 1 | 2014 | 98 | 0.460 |
Why?
|
| Behavior Control | 1 | 2014 | 47 | 0.460 |
Why?
|
| Single-Cell Analysis | 2 | 2018 | 2379 | 0.460 |
Why?
|
| Burns, Chemical | 1 | 2014 | 122 | 0.450 |
Why?
|
| Dental Care for Children | 1 | 2014 | 54 | 0.450 |
Why?
|
| Adrenoleukodystrophy | 1 | 2015 | 143 | 0.440 |
Why?
|
| Porcupines | 1 | 2012 | 2 | 0.440 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2014 | 117 | 0.430 |
Why?
|
| Wound Healing | 8 | 2024 | 2783 | 0.430 |
Why?
|
| Elastomers | 2 | 2012 | 69 | 0.430 |
Why?
|
| Ferric Compounds | 2 | 2012 | 377 | 0.430 |
Why?
|
| Cells, Cultured | 20 | 2016 | 18942 | 0.430 |
Why?
|
| Animal Structures | 1 | 2012 | 24 | 0.430 |
Why?
|
| Stem Cell Transplantation | 5 | 2017 | 1599 | 0.430 |
Why?
|
| Budesonide | 1 | 2014 | 158 | 0.430 |
Why?
|
| Small Molecule Libraries | 2 | 2016 | 724 | 0.420 |
Why?
|
| Decanoates | 4 | 2019 | 55 | 0.420 |
Why?
|
| Dental Care | 1 | 2016 | 279 | 0.420 |
Why?
|
| Genetic Engineering | 3 | 2019 | 933 | 0.420 |
Why?
|
| Receptor, Notch1 | 1 | 2015 | 495 | 0.410 |
Why?
|
| Leukocyte Rolling | 2 | 2010 | 69 | 0.410 |
Why?
|
| Polyglactin 910 | 1 | 2012 | 55 | 0.410 |
Why?
|
| Extracellular Matrix | 3 | 2024 | 1723 | 0.410 |
Why?
|
| Skin Absorption | 2 | 2017 | 94 | 0.410 |
Why?
|
| Microscopy, Electron, Scanning | 7 | 2011 | 940 | 0.390 |
Why?
|
| Skin Physiological Phenomena | 1 | 2012 | 188 | 0.390 |
Why?
|
| Long QT Syndrome | 2 | 2006 | 465 | 0.390 |
Why?
|
| Receptors, Notch | 2 | 2017 | 743 | 0.390 |
Why?
|
| Microfluidic Analytical Techniques | 3 | 2013 | 803 | 0.380 |
Why?
|
| Glycerol | 4 | 2019 | 275 | 0.380 |
Why?
|
| Tooth, Unerupted | 1 | 2011 | 5 | 0.380 |
Why?
|
| Endothelial Cells | 4 | 2013 | 3533 | 0.380 |
Why?
|
| Cell Tracking | 2 | 2011 | 138 | 0.380 |
Why?
|
| Cell Proliferation | 14 | 2021 | 10417 | 0.370 |
Why?
|
| Cytological Techniques | 2 | 2011 | 218 | 0.360 |
Why?
|
| Dermatitis, Contact | 1 | 2011 | 133 | 0.360 |
Why?
|
| Humans | 113 | 2024 | 758381 | 0.360 |
Why?
|
| Engineering | 1 | 2011 | 56 | 0.360 |
Why?
|
| Embryoid Bodies | 1 | 2011 | 65 | 0.360 |
Why?
|
| Nickel | 1 | 2011 | 128 | 0.360 |
Why?
|
| Foreign Bodies | 1 | 2014 | 397 | 0.350 |
Why?
|
| Muscles | 2 | 2012 | 1579 | 0.350 |
Why?
|
| Microscopy, Confocal | 5 | 2019 | 1969 | 0.350 |
Why?
|
| Drug Carriers | 6 | 2018 | 705 | 0.350 |
Why?
|
| Osteogenesis | 5 | 2011 | 1271 | 0.350 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 3709 | 0.350 |
Why?
|
| Colon | 3 | 2015 | 1788 | 0.340 |
Why?
|
| Mice, Inbred BALB C | 6 | 2015 | 6209 | 0.340 |
Why?
|
| Bandages | 1 | 2011 | 269 | 0.340 |
Why?
|
| Nanotechnology | 6 | 2017 | 707 | 0.340 |
Why?
|
| Chelating Agents | 1 | 2011 | 383 | 0.330 |
Why?
|
| Signal Transduction | 10 | 2024 | 23341 | 0.330 |
Why?
|
| Bone Marrow Cells | 5 | 2016 | 2414 | 0.330 |
Why?
|
| Dimethylpolysiloxanes | 3 | 2016 | 142 | 0.330 |
Why?
|
| Mice | 31 | 2024 | 81107 | 0.330 |
Why?
|
| Eating | 2 | 2021 | 1536 | 0.330 |
Why?
|
| Skin | 6 | 2019 | 4464 | 0.320 |
Why?
|
| Physician's Role | 1 | 2016 | 917 | 0.320 |
Why?
|
| Drug Compounding | 5 | 2020 | 245 | 0.310 |
Why?
|
| Cell Survival | 8 | 2021 | 5781 | 0.310 |
Why?
|
| Esophagus | 1 | 2014 | 1023 | 0.310 |
Why?
|
| Incisor | 2 | 2006 | 174 | 0.310 |
Why?
|
| Carotid Arteries | 3 | 2019 | 939 | 0.310 |
Why?
|
| Gastrointestinal Tract | 1 | 2014 | 830 | 0.310 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 1996 | 0.310 |
Why?
|
| Cell Differentiation | 15 | 2022 | 11471 | 0.310 |
Why?
|
| Mice, Inbred C57BL | 10 | 2024 | 22006 | 0.310 |
Why?
|
| Acrylates | 2 | 2019 | 79 | 0.310 |
Why?
|
| Lizards | 1 | 2008 | 50 | 0.300 |
Why?
|
| Child Behavior | 1 | 2014 | 847 | 0.300 |
Why?
|
| Biomedical Engineering | 2 | 2012 | 289 | 0.300 |
Why?
|
| Interleukin-10 | 1 | 2013 | 1174 | 0.300 |
Why?
|
| Models, Biological | 4 | 2019 | 9461 | 0.300 |
Why?
|
| Drug Design | 1 | 2013 | 1049 | 0.290 |
Why?
|
| Polyethylene Glycols | 5 | 2011 | 1188 | 0.290 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2019 | 2420 | 0.290 |
Why?
|
| Intestine, Small | 1 | 2013 | 1207 | 0.290 |
Why?
|
| HL-60 Cells | 6 | 2014 | 363 | 0.290 |
Why?
|
| Glass | 1 | 2007 | 115 | 0.290 |
Why?
|
| Rats | 16 | 2021 | 23681 | 0.280 |
Why?
|
| Flow Cytometry | 6 | 2014 | 5864 | 0.280 |
Why?
|
| Thrombin | 3 | 2006 | 590 | 0.280 |
Why?
|
| Retrograde Obturation | 1 | 2006 | 16 | 0.270 |
Why?
|
| Root Canal Filling Materials | 1 | 2006 | 29 | 0.270 |
Why?
|
| Catheters, Indwelling | 1 | 2009 | 428 | 0.270 |
Why?
|
| Dental Care for Chronically Ill | 1 | 2006 | 32 | 0.270 |
Why?
|
| Cell Physiological Phenomena | 1 | 2007 | 150 | 0.270 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2015 | 1842 | 0.270 |
Why?
|
| Embryonic Stem Cells | 3 | 2008 | 1262 | 0.260 |
Why?
|
| Anilides | 2 | 2020 | 409 | 0.260 |
Why?
|
| Cell Membrane | 3 | 2012 | 3680 | 0.260 |
Why?
|
| Totipotent Stem Cells | 1 | 2005 | 16 | 0.260 |
Why?
|
| Equipment Design | 7 | 2019 | 3507 | 0.260 |
Why?
|
| Multiple Sclerosis | 1 | 2021 | 3204 | 0.260 |
Why?
|
| Arthritis | 1 | 2011 | 666 | 0.250 |
Why?
|
| Excipients | 2 | 2017 | 97 | 0.240 |
Why?
|
| Chitosan | 1 | 2006 | 131 | 0.240 |
Why?
|
| Fibrin | 2 | 2004 | 505 | 0.240 |
Why?
|
| Glucocorticoids | 1 | 2014 | 2144 | 0.240 |
Why?
|
| Prostatic Neoplasms | 5 | 2020 | 11336 | 0.240 |
Why?
|
| Homeostasis | 1 | 2015 | 3302 | 0.230 |
Why?
|
| Shear Strength | 2 | 2016 | 160 | 0.230 |
Why?
|
| Adipocytes | 2 | 2014 | 1177 | 0.230 |
Why?
|
| Poly I-C | 1 | 2024 | 112 | 0.230 |
Why?
|
| Stem Cell Research | 2 | 2015 | 37 | 0.230 |
Why?
|
| Sus scrofa | 3 | 2014 | 428 | 0.230 |
Why?
|
| Bioreactors | 2 | 2020 | 244 | 0.220 |
Why?
|
| Syncope | 1 | 2006 | 427 | 0.220 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2021 | 1111 | 0.210 |
Why?
|
| Neutrophils | 5 | 2020 | 3765 | 0.210 |
Why?
|
| Synovial Fluid | 2 | 2018 | 395 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3076 | 0.210 |
Why?
|
| Chemokine CXCL12 | 2 | 2017 | 454 | 0.210 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2018 | 3755 | 0.210 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2017 | 312 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3196 | 0.200 |
Why?
|
| Delayed-Action Preparations | 4 | 2016 | 961 | 0.200 |
Why?
|
| Fluorescence | 2 | 2019 | 749 | 0.200 |
Why?
|
| Filtration | 1 | 2023 | 227 | 0.200 |
Why?
|
| Genomics | 1 | 2018 | 5789 | 0.200 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 3754 | 0.200 |
Why?
|
| Cell Separation | 5 | 2012 | 1720 | 0.200 |
Why?
|
| Kinetics | 4 | 2019 | 6371 | 0.200 |
Why?
|
| Cell Aggregation | 3 | 2007 | 239 | 0.200 |
Why?
|
| Convection | 1 | 2021 | 30 | 0.200 |
Why?
|
| Staining and Labeling | 3 | 2011 | 1083 | 0.200 |
Why?
|
| Bone Regeneration | 1 | 2004 | 432 | 0.190 |
Why?
|
| Gadolinium DTPA | 2 | 2018 | 823 | 0.190 |
Why?
|
| Pyridines | 3 | 2020 | 2860 | 0.190 |
Why?
|
| Bone Substitutes | 1 | 2003 | 236 | 0.190 |
Why?
|
| Antineoplastic Agents | 4 | 2020 | 13591 | 0.190 |
Why?
|
| Embryo, Mammalian | 1 | 2007 | 1674 | 0.190 |
Why?
|
| Enteroendocrine Cells | 1 | 2022 | 77 | 0.190 |
Why?
|
| Hearing Loss, Sudden | 1 | 2021 | 45 | 0.190 |
Why?
|
| Palliative Care | 1 | 2016 | 3570 | 0.180 |
Why?
|
| Phenotype | 6 | 2015 | 16534 | 0.180 |
Why?
|
| Colitis, Ulcerative | 2 | 2024 | 1919 | 0.180 |
Why?
|
| Masks | 1 | 2023 | 207 | 0.180 |
Why?
|
| Immunomodulation | 2 | 2016 | 545 | 0.180 |
Why?
|
| Particle Size | 3 | 2014 | 1641 | 0.180 |
Why?
|
| Green Fluorescent Proteins | 2 | 2017 | 2057 | 0.180 |
Why?
|
| Cell Line, Tumor | 9 | 2024 | 16886 | 0.170 |
Why?
|
| Immunotherapy | 3 | 2024 | 4641 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 12076 | 0.170 |
Why?
|
| Central Nervous System Diseases | 1 | 2024 | 520 | 0.170 |
Why?
|
| Stress, Mechanical | 3 | 2016 | 1664 | 0.170 |
Why?
|
| Bone Development | 1 | 2003 | 472 | 0.170 |
Why?
|
| Diphtheria Toxin | 1 | 2020 | 252 | 0.170 |
Why?
|
| Swine | 4 | 2019 | 5892 | 0.170 |
Why?
|
| DNA | 2 | 2012 | 7199 | 0.160 |
Why?
|
| Tissue Distribution | 2 | 2021 | 2263 | 0.160 |
Why?
|
| Microtechnology | 2 | 2017 | 70 | 0.160 |
Why?
|
| Syringes | 1 | 2019 | 57 | 0.160 |
Why?
|
| Epithelial Cells | 3 | 2024 | 3665 | 0.160 |
Why?
|
| Injections, Intraperitoneal | 1 | 2019 | 412 | 0.160 |
Why?
|
| Transforming Growth Factor beta | 2 | 2024 | 1957 | 0.150 |
Why?
|
| Hemostatic Techniques | 1 | 2019 | 112 | 0.150 |
Why?
|
| Synthetic Biology | 1 | 2020 | 185 | 0.150 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2018 | 1793 | 0.150 |
Why?
|
| Infusion Pumps | 1 | 2019 | 163 | 0.150 |
Why?
|
| Adhesiveness | 2 | 2019 | 52 | 0.150 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2011 | 617 | 0.150 |
Why?
|
| DNA, Mitochondrial | 1 | 2023 | 856 | 0.150 |
Why?
|
| Transplantation, Homologous | 2 | 2019 | 4809 | 0.150 |
Why?
|
| Sucrose | 1 | 2018 | 156 | 0.150 |
Why?
|
| Aluminum | 1 | 2018 | 152 | 0.150 |
Why?
|
| Neoplasms | 7 | 2024 | 22030 | 0.150 |
Why?
|
| NF-kappa B | 2 | 2016 | 2472 | 0.150 |
Why?
|
| Tacrolimus | 2 | 2019 | 733 | 0.150 |
Why?
|
| Triamcinolone Acetonide | 1 | 2018 | 100 | 0.150 |
Why?
|
| Calcium Phosphates | 2 | 2011 | 171 | 0.150 |
Why?
|
| Endosomes | 1 | 2020 | 519 | 0.150 |
Why?
|
| Porosity | 1 | 2018 | 349 | 0.140 |
Why?
|
| Injections, Subcutaneous | 1 | 2019 | 677 | 0.140 |
Why?
|
| Coculture Techniques | 4 | 2016 | 1339 | 0.140 |
Why?
|
| Pluripotent Stem Cells | 2 | 2015 | 792 | 0.140 |
Why?
|
| Fluorides, Topical | 1 | 2017 | 32 | 0.140 |
Why?
|
| Dexamethasone | 2 | 2015 | 1927 | 0.140 |
Why?
|
| Myocytes, Cardiac | 1 | 2006 | 1655 | 0.140 |
Why?
|
| Collagen Type IV | 1 | 2017 | 127 | 0.140 |
Why?
|
| Injections, Epidural | 1 | 2019 | 200 | 0.140 |
Why?
|
| General Practice, Dental | 1 | 2017 | 33 | 0.140 |
Why?
|
| Transdermal Patch | 1 | 2017 | 51 | 0.140 |
Why?
|
| Polystyrenes | 1 | 2017 | 104 | 0.140 |
Why?
|
| Drug Combinations | 2 | 2017 | 2020 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2021 | 8144 | 0.140 |
Why?
|
| Cancer Vaccines | 1 | 2024 | 1046 | 0.140 |
Why?
|
| Insulin | 3 | 2021 | 6578 | 0.140 |
Why?
|
| Speech Perception | 1 | 2021 | 505 | 0.140 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2021 | 738 | 0.140 |
Why?
|
| Angioplasty | 1 | 2019 | 354 | 0.130 |
Why?
|
| Zinc | 1 | 2020 | 687 | 0.130 |
Why?
|
| Syndecan-1 | 1 | 2017 | 163 | 0.130 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2015 | 398 | 0.130 |
Why?
|
| Collagen | 3 | 2017 | 2635 | 0.130 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 2129 | 0.130 |
Why?
|
| Laminin | 1 | 2017 | 405 | 0.130 |
Why?
|
| Prosthesis Design | 1 | 2003 | 2105 | 0.130 |
Why?
|
| HMGB1 Protein | 1 | 2017 | 137 | 0.130 |
Why?
|
| Rats, Wistar | 5 | 2014 | 1844 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2016 | 4342 | 0.120 |
Why?
|
| Islets of Langerhans | 1 | 2021 | 1345 | 0.120 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2021 | 781 | 0.120 |
Why?
|
| Silver Compounds | 1 | 2014 | 23 | 0.120 |
Why?
|
| Culture Media | 1 | 2017 | 899 | 0.120 |
Why?
|
| Permeability | 2 | 2017 | 718 | 0.120 |
Why?
|
| Eye | 1 | 2019 | 710 | 0.120 |
Why?
|
| Stem Cell Niche | 1 | 2018 | 345 | 0.120 |
Why?
|
| Quantum Theory | 1 | 2014 | 68 | 0.120 |
Why?
|
| Viscosity | 1 | 2015 | 335 | 0.120 |
Why?
|
| Immunity | 1 | 2021 | 998 | 0.120 |
Why?
|
| Vena Cava, Inferior | 1 | 2018 | 458 | 0.120 |
Why?
|
| Organometallic Compounds | 1 | 2018 | 648 | 0.120 |
Why?
|
| Escherichia coli | 2 | 2019 | 4215 | 0.120 |
Why?
|
| Proteoglycans | 1 | 2017 | 801 | 0.120 |
Why?
|
| Health Education, Dental | 1 | 2014 | 26 | 0.120 |
Why?
|
| Gastrointestinal Agents | 1 | 2019 | 508 | 0.120 |
Why?
|
| Hair Cells, Auditory | 1 | 2017 | 379 | 0.120 |
Why?
|
| Molecular Imaging | 2 | 2011 | 815 | 0.110 |
Why?
|
| Membranes, Artificial | 2 | 2008 | 366 | 0.110 |
Why?
|
| Cell Lineage | 2 | 2014 | 2533 | 0.110 |
Why?
|
| Blood Platelets | 3 | 2015 | 2475 | 0.110 |
Why?
|
| Fibroblasts | 4 | 2024 | 4087 | 0.110 |
Why?
|
| Electric Conductivity | 1 | 2014 | 405 | 0.110 |
Why?
|
| Cyclooxygenase 2 | 1 | 2016 | 597 | 0.110 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2019 | 575 | 0.110 |
Why?
|
| Male | 25 | 2024 | 358742 | 0.110 |
Why?
|
| HLA-C Antigens | 1 | 2014 | 147 | 0.110 |
Why?
|
| Cell Line | 4 | 2020 | 15594 | 0.110 |
Why?
|
| Endarterectomy, Carotid | 1 | 2019 | 549 | 0.110 |
Why?
|
| HLA-A Antigens | 1 | 2014 | 225 | 0.110 |
Why?
|
| Tissue Scaffolds | 2 | 2017 | 926 | 0.110 |
Why?
|
| Dental Research | 1 | 2014 | 61 | 0.110 |
Why?
|
| Cyanoacrylates | 1 | 2013 | 46 | 0.110 |
Why?
|
| Amides | 1 | 2016 | 447 | 0.110 |
Why?
|
| Abdominal Wound Closure Techniques | 1 | 2013 | 34 | 0.110 |
Why?
|
| Plasma Cells | 1 | 2017 | 591 | 0.110 |
Why?
|
| Pyrimidines | 2 | 2017 | 3006 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2018 | 2497 | 0.110 |
Why?
|
| Solubility | 2 | 2013 | 1087 | 0.110 |
Why?
|
| Decision Making | 2 | 2018 | 3915 | 0.110 |
Why?
|
| Bioengineering | 1 | 2014 | 96 | 0.110 |
Why?
|
| Maxilla | 2 | 2006 | 491 | 0.110 |
Why?
|
| Drug Implants | 2 | 2019 | 230 | 0.110 |
Why?
|
| Binding Sites | 3 | 2012 | 6036 | 0.110 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2020 | 1613 | 0.110 |
Why?
|
| Dinoprostone | 2 | 2017 | 598 | 0.110 |
Why?
|
| RNA, Small Interfering | 3 | 2021 | 3433 | 0.110 |
Why?
|
| Contrast Media | 3 | 2018 | 5298 | 0.110 |
Why?
|
| Cell Migration Assays | 1 | 2012 | 21 | 0.110 |
Why?
|
| Dental Caries | 1 | 2017 | 420 | 0.110 |
Why?
|
| Chromogranin A | 2 | 2023 | 49 | 0.110 |
Why?
|
| Enzymes | 1 | 2014 | 258 | 0.110 |
Why?
|
| Poultry | 1 | 2012 | 81 | 0.110 |
Why?
|
| Chondrocytes | 1 | 2018 | 791 | 0.100 |
Why?
|
| Phagosomes | 1 | 2014 | 199 | 0.100 |
Why?
|
| HLA-B Antigens | 1 | 2014 | 331 | 0.100 |
Why?
|
| Osmosis | 1 | 2012 | 103 | 0.100 |
Why?
|
| Aorta, Thoracic | 1 | 2019 | 1094 | 0.100 |
Why?
|
| Rabbits | 1 | 2019 | 4771 | 0.100 |
Why?
|
| Stomach | 2 | 2013 | 694 | 0.100 |
Why?
|
| Cell Fractionation | 1 | 2013 | 251 | 0.100 |
Why?
|
| HLA-DR Antigens | 1 | 2014 | 630 | 0.100 |
Why?
|
| Catheters | 1 | 2015 | 421 | 0.100 |
Why?
|
| Body Piercing | 1 | 2012 | 9 | 0.100 |
Why?
|
| Jewelry | 1 | 2012 | 4 | 0.100 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2012 | 103 | 0.100 |
Why?
|
| Commerce | 1 | 2017 | 603 | 0.100 |
Why?
|
| Up-Regulation | 2 | 2015 | 4114 | 0.100 |
Why?
|
| Thiophenes | 1 | 2016 | 569 | 0.100 |
Why?
|
| Karyotyping | 1 | 2013 | 1171 | 0.100 |
Why?
|
| Miniaturization | 3 | 2006 | 153 | 0.100 |
Why?
|
| Cattle | 2 | 2015 | 3846 | 0.100 |
Why?
|
| Selectins | 1 | 2011 | 101 | 0.100 |
Why?
|
| Monocytes | 2 | 2018 | 2570 | 0.100 |
Why?
|
| Immunity, Innate | 2 | 2021 | 3046 | 0.100 |
Why?
|
| Ointments | 1 | 2011 | 58 | 0.100 |
Why?
|
| Tooth Exfoliation | 1 | 2011 | 6 | 0.100 |
Why?
|
| Tooth Eruption, Ectopic | 1 | 2011 | 6 | 0.090 |
Why?
|
| E-Selectin | 1 | 2013 | 576 | 0.090 |
Why?
|
| Pressure | 1 | 2014 | 1155 | 0.090 |
Why?
|
| Mammals | 1 | 2017 | 1132 | 0.090 |
Why?
|
| Biological Products | 1 | 2020 | 906 | 0.090 |
Why?
|
| Tooth Eruption | 1 | 2011 | 29 | 0.090 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2011 | 200 | 0.090 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2015 | 1125 | 0.090 |
Why?
|
| Calcium Carbonate | 1 | 2011 | 62 | 0.090 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2017 | 1113 | 0.090 |
Why?
|
| Bivalvia | 1 | 2010 | 53 | 0.090 |
Why?
|
| Maxillofacial Injuries | 1 | 2011 | 32 | 0.090 |
Why?
|
| Half-Life | 2 | 2009 | 652 | 0.090 |
Why?
|
| Valproic Acid | 1 | 2013 | 442 | 0.090 |
Why?
|
| Gingival Diseases | 1 | 2011 | 36 | 0.090 |
Why?
|
| L-Selectin | 1 | 2011 | 209 | 0.090 |
Why?
|
| Tooth Abnormalities | 1 | 2011 | 56 | 0.090 |
Why?
|
| Intraoperative Period | 1 | 2012 | 512 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 4549 | 0.090 |
Why?
|
| Chromosomes | 1 | 2013 | 575 | 0.090 |
Why?
|
| Edetic Acid | 1 | 2011 | 282 | 0.090 |
Why?
|
| Biotinylation | 1 | 2011 | 184 | 0.090 |
Why?
|
| Cochlea | 1 | 2017 | 844 | 0.090 |
Why?
|
| Elasticity | 2 | 2014 | 652 | 0.090 |
Why?
|
| Paracrine Communication | 1 | 2012 | 276 | 0.090 |
Why?
|
| Jaw Diseases | 1 | 2011 | 92 | 0.090 |
Why?
|
| Ions | 1 | 2011 | 256 | 0.090 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2001 | 0.090 |
Why?
|
| Chondrogenesis | 1 | 2012 | 239 | 0.090 |
Why?
|
| Malocclusion | 1 | 2011 | 131 | 0.090 |
Why?
|
| Weight Loss | 1 | 2021 | 2671 | 0.090 |
Why?
|
| Solvents | 1 | 2011 | 292 | 0.090 |
Why?
|
| Gels | 1 | 2011 | 419 | 0.090 |
Why?
|
| Fibronectins | 1 | 2013 | 722 | 0.090 |
Why?
|
| Professional-Family Relations | 1 | 2014 | 495 | 0.090 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 1335 | 0.080 |
Why?
|
| Mice, Nude | 1 | 2016 | 3602 | 0.080 |
Why?
|
| Blood Glucose | 2 | 2021 | 6347 | 0.080 |
Why?
|
| Cytoplasm | 1 | 2014 | 1514 | 0.080 |
Why?
|
| Light | 1 | 2015 | 1345 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 2 | 2018 | 2796 | 0.080 |
Why?
|
| High-Throughput Screening Assays | 1 | 2015 | 933 | 0.080 |
Why?
|
| Mouth | 1 | 2012 | 380 | 0.080 |
Why?
|
| North America | 1 | 2012 | 1276 | 0.080 |
Why?
|
| Internship and Residency | 2 | 2022 | 5865 | 0.080 |
Why?
|
| Antibodies | 1 | 2017 | 2420 | 0.080 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2011 | 461 | 0.080 |
Why?
|
| Cell Size | 1 | 2011 | 623 | 0.080 |
Why?
|
| Transfection | 2 | 2014 | 5779 | 0.080 |
Why?
|
| Streptavidin | 1 | 2008 | 82 | 0.080 |
Why?
|
| Biomedical Research | 2 | 2015 | 3417 | 0.080 |
Why?
|
| Xylenes | 1 | 2008 | 8 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2018 | 36285 | 0.080 |
Why?
|
| Mentors | 1 | 2014 | 660 | 0.080 |
Why?
|
| Coloring Agents | 1 | 2011 | 560 | 0.080 |
Why?
|
| Adipogenesis | 1 | 2011 | 358 | 0.080 |
Why?
|
| Graft Survival | 2 | 2019 | 3794 | 0.070 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2018 | 1426 | 0.070 |
Why?
|
| Biotin | 1 | 2008 | 253 | 0.070 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 632 | 0.070 |
Why?
|
| Carmustine | 1 | 2007 | 138 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2021 | 3941 | 0.070 |
Why?
|
| Prostate | 1 | 2016 | 1791 | 0.070 |
Why?
|
| Graft vs Host Disease | 1 | 2020 | 3024 | 0.070 |
Why?
|
| Child | 6 | 2022 | 79813 | 0.070 |
Why?
|
| Documentation | 1 | 2014 | 892 | 0.070 |
Why?
|
| Time Factors | 8 | 2019 | 39873 | 0.070 |
Why?
|
| Serum Albumin, Bovine | 1 | 2008 | 322 | 0.070 |
Why?
|
| Blood Proteins | 1 | 2013 | 1173 | 0.070 |
Why?
|
| Informed Consent | 1 | 2014 | 1003 | 0.070 |
Why?
|
| Magnetics | 1 | 2010 | 600 | 0.070 |
Why?
|
| Epoxy Compounds | 1 | 2007 | 137 | 0.070 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2009 | 237 | 0.070 |
Why?
|
| Gliosarcoma | 1 | 2007 | 113 | 0.070 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 2204 | 0.070 |
Why?
|
| Pyrazoles | 1 | 2017 | 1990 | 0.070 |
Why?
|
| Hemorrhage | 1 | 2019 | 3400 | 0.070 |
Why?
|
| Leukocytes | 2 | 2012 | 2025 | 0.070 |
Why?
|
| Female | 15 | 2024 | 390316 | 0.070 |
Why?
|
| Clinical Trials as Topic | 2 | 2014 | 7985 | 0.070 |
Why?
|
| Receptors, Cell Surface | 3 | 2015 | 2825 | 0.070 |
Why?
|
| Heterozygote | 1 | 2013 | 2797 | 0.070 |
Why?
|
| Myocardial Ischemia | 1 | 2017 | 2108 | 0.070 |
Why?
|
| Colitis | 1 | 2015 | 1231 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2021 | 3432 | 0.070 |
Why?
|
| Aldehydes | 1 | 2007 | 170 | 0.070 |
Why?
|
| Tooth Replantation | 1 | 2006 | 10 | 0.070 |
Why?
|
| Tooth Apex | 1 | 2006 | 28 | 0.070 |
Why?
|
| Aluminum Compounds | 1 | 2006 | 55 | 0.070 |
Why?
|
| Veins | 1 | 2011 | 765 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2017 | 2912 | 0.070 |
Why?
|
| Calcium Compounds | 1 | 2006 | 38 | 0.070 |
Why?
|
| Interleukin-8 | 1 | 2009 | 696 | 0.070 |
Why?
|
| Silicates | 1 | 2006 | 47 | 0.070 |
Why?
|
| Lipase | 1 | 2008 | 324 | 0.070 |
Why?
|
| Root Resorption | 1 | 2006 | 44 | 0.070 |
Why?
|
| Teaching | 1 | 2014 | 1168 | 0.070 |
Why?
|
| Wounds and Injuries | 1 | 2019 | 2476 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 15396 | 0.070 |
Why?
|
| Prostate-Specific Antigen | 1 | 2016 | 2528 | 0.070 |
Why?
|
| Amines | 1 | 2007 | 281 | 0.070 |
Why?
|
| Cryopreservation | 1 | 2011 | 717 | 0.060 |
Why?
|
| Absorbable Implants | 1 | 2008 | 338 | 0.060 |
Why?
|
| Interferon-gamma | 1 | 2014 | 3156 | 0.060 |
Why?
|
| Cardiomyopathies | 1 | 2017 | 1944 | 0.060 |
Why?
|
| RNA Interference | 1 | 2014 | 2836 | 0.060 |
Why?
|
| Bone Matrix | 1 | 2005 | 118 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2021 | 64379 | 0.060 |
Why?
|
| Osteocalcin | 1 | 2005 | 274 | 0.060 |
Why?
|
| Receptor, PAR-1 | 1 | 2005 | 109 | 0.060 |
Why?
|
| Blood Vessels | 1 | 2010 | 1112 | 0.060 |
Why?
|
| Pierre Robin Syndrome | 1 | 2006 | 117 | 0.060 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 1332 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 4313 | 0.060 |
Why?
|
| Proteomics | 1 | 2018 | 3816 | 0.060 |
Why?
|
| Integrins | 1 | 2009 | 836 | 0.060 |
Why?
|
| Oxides | 1 | 2006 | 401 | 0.060 |
Why?
|
| Microspheres | 1 | 2007 | 787 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3801 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2017 | 3069 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 5484 | 0.060 |
Why?
|
| Metal Nanoparticles | 1 | 2008 | 396 | 0.060 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2011 | 1431 | 0.060 |
Why?
|
| Urologic Diseases | 1 | 2006 | 248 | 0.060 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2009 | 1110 | 0.060 |
Why?
|
| Pandemics | 2 | 2022 | 8611 | 0.060 |
Why?
|
| Education, Graduate | 1 | 2004 | 75 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2011 | 1927 | 0.060 |
Why?
|
| Colon, Sigmoid | 1 | 2024 | 124 | 0.060 |
Why?
|
| Catheterization | 1 | 2009 | 1426 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2008 | 1865 | 0.060 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2007 | 617 | 0.050 |
Why?
|
| Biopsy | 1 | 2015 | 6768 | 0.050 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 1897 | 0.050 |
Why?
|
| Rats, Inbred Strains | 1 | 2004 | 2090 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2024 | 1651 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 10171 | 0.050 |
Why?
|
| Societies, Scientific | 1 | 2004 | 220 | 0.050 |
Why?
|
| Photography | 1 | 2006 | 530 | 0.050 |
Why?
|
| Cell Polarity | 1 | 2006 | 638 | 0.050 |
Why?
|
| Lab-On-A-Chip Devices | 2 | 2017 | 432 | 0.050 |
Why?
|
| Models, Animal | 2 | 2019 | 2112 | 0.050 |
Why?
|
| Alkaline Phosphatase | 1 | 2005 | 865 | 0.050 |
Why?
|
| Health Care Sector | 1 | 2004 | 193 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 3990 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2017 | 5629 | 0.050 |
Why?
|
| Anthracenes | 1 | 2022 | 83 | 0.050 |
Why?
|
| Polytetrafluoroethylene | 1 | 2003 | 245 | 0.050 |
Why?
|
| Tissue Fixation | 1 | 2003 | 241 | 0.050 |
Why?
|
| Inservice Training | 1 | 2004 | 375 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2014 | 12760 | 0.050 |
Why?
|
| Osseointegration | 1 | 2003 | 274 | 0.050 |
Why?
|
| Bone Marrow | 2 | 2017 | 2909 | 0.050 |
Why?
|
| Safety | 1 | 2006 | 1147 | 0.050 |
Why?
|
| Peptide YY | 1 | 2022 | 136 | 0.050 |
Why?
|
| Administration, Inhalation | 1 | 2024 | 1153 | 0.050 |
Why?
|
| Speech Intelligibility | 1 | 2021 | 79 | 0.050 |
Why?
|
| Bone Cements | 1 | 2003 | 324 | 0.050 |
Why?
|
| Hepatocytes | 1 | 2008 | 1230 | 0.050 |
Why?
|
| Endocannabinoids | 1 | 2022 | 111 | 0.050 |
Why?
|
| Growth Substances | 1 | 2003 | 768 | 0.050 |
Why?
|
| Animals, Newborn | 1 | 2006 | 2673 | 0.050 |
Why?
|
| Macrophages | 1 | 2015 | 5737 | 0.040 |
Why?
|
| Mass Screening | 1 | 2016 | 5425 | 0.040 |
Why?
|
| Curriculum | 1 | 2014 | 3717 | 0.040 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2020 | 133 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2006 | 1240 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2006 | 1436 | 0.040 |
Why?
|
| Lymphocyte Subsets | 1 | 2021 | 310 | 0.040 |
Why?
|
| Image Enhancement | 1 | 2011 | 2880 | 0.040 |
Why?
|
| Random Allocation | 1 | 2004 | 2385 | 0.040 |
Why?
|
| Parents | 1 | 2014 | 3548 | 0.040 |
Why?
|
| Somatostatin | 1 | 2022 | 447 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 13245 | 0.040 |
Why?
|
| Inflammation Mediators | 2 | 2021 | 1878 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 2021 | 1317 | 0.040 |
Why?
|
| Sheep, Domestic | 1 | 2019 | 50 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 2557 | 0.040 |
Why?
|
| Obesity | 1 | 2021 | 12870 | 0.040 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2022 | 362 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2024 | 1203 | 0.040 |
Why?
|
| Multiple Myeloma | 1 | 2017 | 5129 | 0.040 |
Why?
|
| Universities | 1 | 2004 | 993 | 0.040 |
Why?
|
| Forelimb | 1 | 2019 | 115 | 0.040 |
Why?
|
| Insulin Infusion Systems | 1 | 2020 | 217 | 0.040 |
Why?
|
| Bioprosthesis | 1 | 2003 | 591 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 3480 | 0.040 |
Why?
|
| Myocardium | 1 | 2011 | 4690 | 0.040 |
Why?
|
| Hemolysis | 1 | 2020 | 423 | 0.040 |
Why?
|
| Quinolones | 1 | 2022 | 377 | 0.040 |
Why?
|
| Femur | 1 | 2004 | 1302 | 0.040 |
Why?
|
| Blood | 2 | 2014 | 586 | 0.040 |
Why?
|
| Actins | 1 | 2005 | 2049 | 0.040 |
Why?
|
| Career Choice | 1 | 2004 | 752 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2023 | 1745 | 0.040 |
Why?
|
| Decanoic Acids | 2 | 2007 | 68 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5649 | 0.040 |
Why?
|
| Quality of Life | 1 | 2019 | 13286 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 14641 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2014 | 4673 | 0.040 |
Why?
|
| Fibrosis | 1 | 2024 | 2038 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 11894 | 0.030 |
Why?
|
| Laparoscopy | 1 | 2009 | 2147 | 0.030 |
Why?
|
| Chemical Engineering | 1 | 2016 | 15 | 0.030 |
Why?
|
| Swine, Miniature | 1 | 2019 | 959 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2023 | 2209 | 0.030 |
Why?
|
| Biological Availability | 1 | 2017 | 390 | 0.030 |
Why?
|
| Microinjections | 1 | 2017 | 321 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 18125 | 0.030 |
Why?
|
| Benzylamines | 1 | 2017 | 247 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 9405 | 0.030 |
Why?
|
| Heterocyclic Compounds | 1 | 2017 | 246 | 0.030 |
Why?
|
| NIH 3T3 Cells | 2 | 2008 | 670 | 0.030 |
Why?
|
| Ligands | 2 | 2014 | 3258 | 0.030 |
Why?
|
| Data Collection | 1 | 2004 | 3322 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 20500 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2016 | 522 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 2017 | 712 | 0.030 |
Why?
|
| Bacterial Toxins | 1 | 2020 | 931 | 0.030 |
Why?
|
| Protein Transport | 1 | 2020 | 1963 | 0.030 |
Why?
|
| Organogenesis | 1 | 2016 | 215 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 2017 | 695 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1788 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 1018 | 0.030 |
Why?
|
| Students | 1 | 2004 | 1734 | 0.030 |
Why?
|
| Intellectual Property | 1 | 2013 | 31 | 0.030 |
Why?
|
| Age Factors | 1 | 2011 | 18357 | 0.030 |
Why?
|
| Chickens | 1 | 2016 | 860 | 0.030 |
Why?
|
| Adolescent | 3 | 2019 | 87888 | 0.030 |
Why?
|
| Cytokines | 2 | 2021 | 7338 | 0.030 |
Why?
|
| Lipids | 1 | 2024 | 3326 | 0.030 |
Why?
|
| United States | 3 | 2022 | 72140 | 0.030 |
Why?
|
| Gastric Bypass | 1 | 2021 | 817 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2006 | 6363 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2012 | 87 | 0.030 |
Why?
|
| Complement Activation | 1 | 2014 | 446 | 0.030 |
Why?
|
| Infant | 1 | 2014 | 36054 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2014 | 1060 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2003 | 2560 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 3574 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 7810 | 0.020 |
Why?
|
| Tooth Injuries | 1 | 2012 | 18 | 0.020 |
Why?
|
| Internet | 1 | 2004 | 3082 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2017 | 841 | 0.020 |
Why?
|
| Palate, Hard | 1 | 2012 | 58 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 42058 | 0.020 |
Why?
|
| Interferon-beta | 1 | 2013 | 345 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 7590 | 0.020 |
Why?
|
| Reference Standards | 1 | 2015 | 1003 | 0.020 |
Why?
|
| Complement System Proteins | 1 | 2014 | 782 | 0.020 |
Why?
|
| Endoscopy | 1 | 2021 | 1834 | 0.020 |
Why?
|
| Cell-Derived Microparticles | 1 | 2012 | 161 | 0.020 |
Why?
|
| Drug Approval | 1 | 2018 | 809 | 0.020 |
Why?
|
| Body Weight | 1 | 2021 | 4603 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2012 | 341 | 0.020 |
Why?
|
| Temperature | 2 | 2007 | 2219 | 0.020 |
Why?
|
| Microvilli | 1 | 2010 | 233 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 11424 | 0.020 |
Why?
|
| Lip | 1 | 2012 | 197 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2012 | 691 | 0.020 |
Why?
|
| Immunity, Humoral | 1 | 2014 | 604 | 0.020 |
Why?
|
| Mitochondria | 1 | 2023 | 3584 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2010 | 505 | 0.020 |
Why?
|
| Necrosis | 1 | 2013 | 1604 | 0.020 |
Why?
|
| Vascular Grafting | 1 | 2011 | 152 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 2012 | 426 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 20052 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 1076 | 0.020 |
Why?
|
| Tongue | 1 | 2012 | 404 | 0.020 |
Why?
|
| Embryo Research | 1 | 2008 | 38 | 0.020 |
Why?
|
| Microvessels | 1 | 2012 | 572 | 0.020 |
Why?
|
| Point-of-Care Systems | 1 | 2017 | 1201 | 0.020 |
Why?
|
| Protein Binding | 1 | 2020 | 9312 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2021 | 11070 | 0.020 |
Why?
|
| Synapses | 1 | 2017 | 1757 | 0.020 |
Why?
|
| Dicarboxylic Acids | 1 | 2007 | 77 | 0.020 |
Why?
|
| Cell Division | 2 | 2006 | 4459 | 0.020 |
Why?
|
| Sepharose | 1 | 2007 | 105 | 0.020 |
Why?
|
| Drug Stability | 1 | 2007 | 290 | 0.020 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2007 | 222 | 0.020 |
Why?
|
| Middle Aged | 4 | 2024 | 219560 | 0.020 |
Why?
|
| Silicon | 1 | 2007 | 142 | 0.020 |
Why?
|
| Triglycerides | 1 | 2014 | 2450 | 0.020 |
Why?
|
| SELEX Aptamer Technique | 1 | 2006 | 18 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2006 | 148 | 0.020 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2007 | 275 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2007 | 825 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2007 | 664 | 0.020 |
Why?
|
| Flow Injection Analysis | 1 | 2005 | 21 | 0.020 |
Why?
|
| Adult | 4 | 2024 | 219916 | 0.020 |
Why?
|
| Alkylating Agents | 1 | 2006 | 133 | 0.020 |
Why?
|
| Microscopy | 1 | 2011 | 884 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2021 | 54136 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2019 | 4426 | 0.020 |
Why?
|
| Polyesters | 1 | 2007 | 371 | 0.020 |
Why?
|
| Mitomycin | 1 | 2006 | 262 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2007 | 610 | 0.020 |
Why?
|
| Pregnancy | 1 | 2007 | 29742 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 3526 | 0.020 |
Why?
|
| Acetaminophen | 1 | 2008 | 552 | 0.010 |
Why?
|
| Heart | 1 | 2017 | 4382 | 0.010 |
Why?
|
| Disease Progression | 1 | 2021 | 13468 | 0.010 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 3840 | 0.010 |
Why?
|
| Radiography | 1 | 2015 | 6955 | 0.010 |
Why?
|
| Gene Expression | 1 | 2016 | 7583 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2021 | 22031 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2019 | 3783 | 0.010 |
Why?
|
| Equipment Failure Analysis | 1 | 2005 | 843 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2006 | 685 | 0.010 |
Why?
|
| Platelet Activation | 1 | 2006 | 645 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2022 | 12096 | 0.010 |
Why?
|
| Brain | 2 | 2021 | 26951 | 0.010 |
Why?
|
| Mutation | 1 | 2006 | 29915 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2012 | 2606 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 25953 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2014 | 5952 | 0.010 |
Why?
|
| Biological Assay | 1 | 2003 | 626 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 3705 | 0.010 |
Why?
|
| Models, Anatomic | 1 | 2003 | 681 | 0.010 |
Why?
|
| Young Adult | 2 | 2019 | 58808 | 0.010 |
Why?
|
| Medical Oncology | 1 | 1991 | 2312 | 0.010 |
Why?
|
| Kidney | 1 | 2014 | 7016 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2008 | 3380 | 0.010 |
Why?
|
| Liver | 1 | 2014 | 7502 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2008 | 5410 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2017 | 6363 | 0.010 |
Why?
|
| Aged | 2 | 2021 | 168217 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2007 | 3758 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 10747 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 12436 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 58681 | 0.010 |
Why?
|
| Training Support | 1 | 1991 | 108 | 0.010 |
Why?
|
| Research Support as Topic | 1 | 1991 | 697 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2012 | 80170 | 0.000 |
Why?
|
| Research | 1 | 1991 | 1976 | 0.000 |
Why?
|